Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
HEYMACH, JOHN VICTOR
One or more keywords matched the following items that are connected to HEYMACH, JOHN VICTOR
Item TypeName
Academic Article Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
Concept Indoles
Academic Article Circulating biomarkers of response to sunitinib in gastroenteropancreatic neuroendocrine tumors: current data and clinical outlook.
Academic Article Inhibition of intra-abdominal adhesion formation with the angiogenesis inhibitor sunitinib.
Academic Article Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
Academic Article Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor.
Academic Article Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomas.
Academic Article Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668.
Academic Article Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.
Academic Article Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours.
Academic Article Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer.
Academic Article Targeting angiogenesis for patients with unresectable malignant pleural mesothelioma.
Academic Article A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer.
Academic Article Osimertinib, Surgery, and Radiation Therapy in Treating Patients with Stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR).
Academic Article Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC.
Academic Article Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
Search Criteria
  • Indoles